← Back to headlines
Experimental Drug Diranersen Shows Promising Early Results for Alzheimer's
An experimental drug, diranersen, has shown encouraging early results in individuals with mild cognitive impairment and early Alzheimer's disease, according to an announcement in London.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
